CUSIP 26818M108COMDYNQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
230 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Janus Henderson Group PLC | 13.89M | $271.60M | −857.8K | Reduced |
| 2 | Vanguard Group Inc | 11.22M | $219.38M | +1.46M | Added |
| 3 | Blackrock, Inc. | 11.19M | $218.89M | +1.56M | Added |
| 4 | Atlas Venture Life Science Advisors, LLC | 9.13M | $178.59M |
| 0 |
| Held |
| 5 | State Street Corp | 6.69M | $130.91M | +1.42M | Added |
| 6 | Fmr LLC | 6.57M | $128.51M | +1.17M | Added |
| 7 | Fcpm III Services B.V. | 5.46M | $106.85M | 0 | Held |
| 8 | Adage Capital Partners Gp, L.L.C. | 5.17M | $101.16M | +1.62M | Added |
| 9 | Orbis Allan Gray Ltd | 4.80M | $93.93M | +4.80M | New |
| 10 | Tcg Crossover Management, LLC | 4.62M | $90.27M | 0 | Held |
See every fund holding Dyne Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders